论文部分内容阅读
目的探讨临床药师对经皮冠状动脉介入治疗(PCI)术后患者的药学监护,为心内科临床药师开展药学服务提供参考。方法临床药师对1例PCI术后患者反复出现支架内再狭窄的因素进行分析,分别从抗血小板药物治疗的基因多态性、术后血脂和血糖的控制、用药依从性教育和出院后电话随访等方面提出建议并进行药学监护。结果与结论临床药师为临床医师对该患者药物治疗方案的调整提供了合理的建议并对其实施药学监护,半年后电话回访未出现心血管不良事件和药物不良反应,为其安全有效地用药提供保障,并提高用药依从性。
Objective To investigate the pharmacological nursing of patients after percutaneous coronary intervention (PCI) by clinical pharmacists and provide references for clinical pharmacists to carry out pharmacy services. Methods Clinical pharmacists analyzed recurrence factors of in-stent restenosis in one patient after PCI. From the genetic polymorphism of antiplatelet drugs, postoperative blood lipid and blood glucose control, drug compliance education and telephone follow-up after discharge And other aspects of the proposal and conduct pharmacy care. RESULTS AND CONCLUSION: The clinical pharmacist provided reasonable advice to the clinician to adjust the medication regimen of the patient and implemented the pharmacy guardianship. After six months, there was no cardiovascular adverse events and adverse drug reactions during the telephone interview, providing safe and effective medication Protection, and improve medication compliance.